Lung cancer

You have access
Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report
ANNAPAOLA MARINIELLO, ELEONORA GHISONI, LUISELLA RIGHI, ANNAMARIA CATINO, RITA CHIARI, ALESSANDRO DEL CONTE, FAUSTO BARBIERI, FABIANA CECERE, ALAIN GELIBTER, MATTEO GIAJLEVRA, HECTOR SOTO PARRA, CLIZIA ZICHI, MASSIMO DI MAIO, GIORGIO VALABREGA and SILVIA NOVELLO

In Vivo November 2019, 33 (6) 2021-2026; DOI: https://doi.org/10.21873/invivo.11699
You have access
Granulation Tissue-induced Pseudo-relapse During Nivolumab Treatment in Advanced Non-small Cell Lung Cancer
CHIHIRO ANDO, EIKI ICHIHARA, HIROHISA KANO, YOSHITAKA IWAMOTO, ATSUKO HIRABAE, TAKAMASA NAKASUKA, YOSHINOBU MAEDA and KATSUYUKI KIURA

In Vivo November 2019, 33 (6) 2113-2115; DOI: https://doi.org/10.21873/invivo.11711
You have access
Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer
VILEM MALY, ONDREJ MALY, KATARINA KOLOSTOVA and VLADIMIR BOBEK

In Vivo July 2019, 33 (4) 1027-1037; DOI: https://doi.org/10.21873/invivo.11571
You have access
Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting EGFR Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural Effusion
SANG HOON JEON, HYUNG WOO KIM, BIT NA KIM, NAHYEON KANG, CHANG DONG YEO, CHAN KWON PARK, YOUNG KYOON KIM, YOON HO LEE, TAE-JUNG KIM, KYO YOUNG LEE, SUG HYUNG LEE, JONG Y. PARK, MI SUN PARK, HYEON WOO YIM and SEUNG JOON KIM

In Vivo March 2019, 33 (2) 595-603; DOI: https://doi.org/10.21873/invivo.11516
You have access
Neutrophil–to–Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer
HIROSHI DOI, KIYOSHI NAKAMATSU, SHIMPEI ANAMI, KOHEI FUKUDA, MASAHIRO INADA, HITOSHI TATEBE, KAZUKI ISHIKAWA, SHUICHI KANAMORI, HAJIME MONZEN and YASUMASA NISHIMURA

In Vivo January 2019, 33 (1) 195-201; DOI: https://doi.org/10.21873/invivo.11459
You have access
Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD
PAUL FLECHSIG, OLENA HURAL, MICHAEL KREUTER, MARTIN EICHHORN, GUDULA HEUßEL, CHRISTOS SACHPEKIDIS, HANS-ULRICH KAUCZOR, UWE HABERKORN, CLAUS PETER HEUSSEL and MONIKA EICHINGER

In Vivo November 2018, 32 (6) 1457-1462; DOI: https://doi.org/10.21873/invivo.11399
You have access
Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma
ROLANDAS ZABLOCKIS, EDVARDAS ŽURAUSKAS, EDVARDAS DANILA and VYGANTAS GRUSLYS

In Vivo November 2018, 32 (6) 1571-1579; DOI: https://doi.org/10.21873/invivo.11416
You have access
A Case of a Pregnant Woman Diagnosed as Having ALK-rearranged Lung Adenocarcinoma
MOEGI KOMURA, SHIGEHIRO YAGISHITA, KOTA NAKAMURA, NAOKO ARANO, TOMOHITO TAKESHIGE, KEIKO MURAKI, OSAMU NAGASHIMA, HIROSHI IZUMI, SHIGEKI TOMITA, SHINICHI SASAKI and KAZUHISA TAKAHASHI

In Vivo September 2018, 32 (5) 1205-1209; DOI: https://doi.org/10.21873/invivo.11365
You have access
Association Between Imaging Findings of Airway Obstruction Adjacent to Lung Tumors and the Onset of Interstitial Lung Disease After Nivolumab
KENJI NAKAHAMA, AKIHIRO TAMIYA, SHUN-ICHI ISA, YOSHIHIKO TANIGUCHI, TAKAYUKI SHIROYAMA, HIDEKAZU SUZUKI, TAKAKO INOUE, MOTOHIRO TAMIYA, TOMONORI HIRASHIMA, FUMIO IMAMURA and SHINJI ATAGI

In Vivo July 2018, 32 (4) 887-891; DOI: https://doi.org/10.21873/invivo.11324
You have access
How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?
CARSTEN NIEDER, ROSALBA YOBUTA, BÅRD MANNSÅKER and ASTRID DALHAUG

In Vivo March 2018, 32 (2) 331-336;

Main menu

User menu

Search

Lung cancer

Pages